AFC Gamma Q1 Earnings: Cannabis Lender Faces Margin Pressure

AFC Gamma delivered a challenging first quarter that underscores the evolving pressures facing specialized cannabis lenders in an increasingly competitive market. The real estate investment trust, which focuses exclusively on providing loans secured by cannabis licenses and facilities, reported results that reflect both the opportunities and risks inherent in the cannabis financing sector.

Revenue Growth Offset by Rising Costs

AFCG generated $23.4 million in total revenue for Q1, representing a 12% increase year-over-year but falling short of the $24.8 million consensus estimate. The company's net interest margin compressed to 8.2% from 9.1% in the prior year period, as increased competition among cannabis lenders pressured pricing on new originations. Management attributed the margin decline to borrowers having more financing options available, forcing AFC Gamma to accept lower spreads to maintain deal flow.

The company's loan portfolio reached $847 million at quarter-end, up from $782 million three months earlier. However, the 8.3% quarterly growth rate marked the slowest expansion pace in over two years, signaling potential headwinds in the cannabis lending market. AFCG's average loan yield declined to 13.8% from 14.4% in Q4, reflecting the competitive dynamics management highlighted.

Credit Quality Concerns Emerge

AFC Gamma's provision for credit losses increased to $3.2 million in Q1, compared to $1.8 million in the previous quarter. The company moved $18 million in loans to non-accrual status, primarily related to two borrowers facing operational challenges in oversupplied state markets. These credit issues contributed to distributable earnings per share of $0.42, down from $0.48 in Q4 and below analyst expectations of $0.45.

The cannabis industry's maturation brings both opportunities and risks, and we're seeing some borrowers struggle with market saturation in certain states.

Management emphasized that the credit issues remain isolated to specific markets experiencing oversupply, particularly California and Colorado. The company maintains that its collateral-heavy lending approach, with loans secured by valuable cannabis licenses and real estate, provides downside protection even in stressed scenarios.

Market Positioning and Outlook

Despite near-term challenges, AFC Gamma continues to benefit from the cannabis industry's capital-intensive nature and limited access to traditional banking services. The company originated $127 million in new loans during Q1, though this represented a 22% decline from the previous quarter's record pace. Management attributed the slowdown to increased selectivity rather than reduced market demand.

The REIT maintained its quarterly dividend at $0.40 per share, though the 95% payout ratio based on distributable earnings leaves little cushion for potential credit losses or margin compression. AFCG's book value per share declined to $12.85 from $13.12 at year-end, reflecting the challenging operating environment.

Looking ahead, AFC Gamma expects continued pressure on loan pricing as more capital enters the cannabis lending space. However, management believes the company's specialized expertise and established relationships with cannabis operators provide competitive advantages in underwriting and structuring complex transactions. The firm projects loan portfolio growth of 15-20% for the full year, down from previous guidance of 20-25%, reflecting a more cautious market outlook.

AFC Gamma's Q1 results illustrate the cannabis lending sector's evolution from a high-margin niche to a more competitive, normalized financing market. While this transition pressures near-term profitability, it also signals the cannabis industry's continued maturation and integration into broader capital markets. Investors will watch closely to see how AFCG adapts its strategy to maintain returns in this changing landscape.